US20200230052A1 - Oral product - Google Patents

Oral product Download PDF

Info

Publication number
US20200230052A1
US20200230052A1 US16/840,820 US202016840820A US2020230052A1 US 20200230052 A1 US20200230052 A1 US 20200230052A1 US 202016840820 A US202016840820 A US 202016840820A US 2020230052 A1 US2020230052 A1 US 2020230052A1
Authority
US
United States
Prior art keywords
oral product
fiber
polymer matrix
oral
mouth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US16/840,820
Other versions
US11541001B2 (en
Inventor
Feng Gao
Frank Scott Atchley
Gregory James Griscik
Christopher Joseph DiNovi
Phillip M. Hulan
Diane L. Gee
Gerd Kobal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altria Client Services LLC
Original Assignee
Altria Client Services LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altria Client Services LLC filed Critical Altria Client Services LLC
Priority to US16/840,820 priority Critical patent/US11541001B2/en
Publication of US20200230052A1 publication Critical patent/US20200230052A1/en
Priority to US18/055,983 priority patent/US20230074150A1/en
Application granted granted Critical
Publication of US11541001B2 publication Critical patent/US11541001B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Definitions

  • This document relates to oral products including mouth-stable polymers and one or more additives.
  • Oral products providing flavor and/or one or more active ingredients are well known.
  • One such oral product is chewing gum.
  • Other oral products include hard candies (e.g., mints).
  • Softer gelatin-based oral products are also known.
  • Pharmaceutical and therapeutic products e.g., cough-suppressant lozenges
  • the flavor release and/or active agent release characteristics for an oral product are important for providing an improved consumer product.
  • the oral product includes a body that is at least partially receivable in an oral cavity of a consumer.
  • the body includes a mouth-stable polymer matrix, cellulosic fibers embedded in the stable polymer matrix, and one or more additives dispersed in the body such that it is released when the body is received within the oral cavity and exposed to saliva.
  • the oral product includes flavorants, sweeteners, vitamins, minerals, therapeutic agents, nutraceuticals, energizing agents, soothing agents, coloring agents, amino acids, chemsthetic agents, antioxidants, food grade emulsifiers, pH modifiers, botanicals, teeth whitening agents, and/or alkaloids (e.g., caffeine).
  • additives e.g., sweeteners, flavorants, and caffeine
  • the oral product's body includes at least 10 weight percent of the mouth-stable polymer.
  • the mouth-stable polymer matrix can include polyurethane, silicon polymer, polyester, polyacrylate, polyethylene, poly(styrene-ethylene-butylene-styrene) (“SEBS”), poly(styrene-butadiene-styrene) (“SBS”), poly(styrene-isoprene-styrene)(“SIS”), and other similar thermoplastic elastomers, or any copolymer, mixture, or combination thereof.
  • SEBS poly(styrene-ethylene-butylene-styrene)
  • SBS poly(styrene-butadiene-styrene)
  • SIS poly(styrene-isoprene-styrene)
  • the oral product can also include a plasticizer dispersed in the mouth-stable polymer matrix.
  • the plasticizer can be propylene glycol, glycerin, vegetable oil, triglycerides, or a combination thereof.
  • the oral product can also include a sweetener dispersed in the body.
  • the sweetener can be saccharine, sucralose, aspartame, acesulfame potassium, or a combination thereof.
  • the oral product can include an additive selected from the group consisting of minerals, vitamins, dietary supplements, nutraceuticals, energizing agents, soothing agents, amino acids, chemsthetic agents, antioxidants, botanicals, teeth whitening agents, therapeutic agents, or a combination thereof.
  • the additives can be absorbed into the cellulosic fibers and polymer matrix.
  • the oral product's body can have at least 10 weight percent cellulosic fibers.
  • the cellulosic fibers can be derived from plant tissue.
  • the cellulosic fibers include cellulose.
  • the cellulosic fibers can further include lignin and/or lipids.
  • the cellulosic fibers can be selected from the following: sugar beet fiber, wood pulp fiber, cotton fiber, bran fiber, citrus pulp fiber, grass fiber, willow fiber, poplar fiber, and combinations thereof.
  • the cellulosic fibers may also be chemically treated prior to use.
  • the cellulosic fibers can be CMC, HPMC, HPC, or other treated cellulosic material.
  • the oral product can include flavorants.
  • the flavorants can be natural or artificial.
  • Flavorants can be selected from the following: licorice, wintergreen, cherry and berry type flavorants, Drambuie, bourbon, scotch, whiskey, spearmint, peppermint, lavender, cinnamon, cardamon, apium graveolents, clove, cascarilla, nutmeg, sandalwood, bergamot, geranium, honey essence, rose oil, vanilla, lemon oil, orange oil, Japanese mint, cassia, caraway, cognac, jasmin, chamomile, menthol, ylang ylang, sage, fennel, pimenta, ginger, anise, coriander, coffee, mint oils from a species of the genus Mentha, cocoa, and combinations thereof.
  • Synthetic flavorants can also be used.
  • the particular combination of flavorants can be selected from the flavorants that are generally recognized as safe (“GRAS”) in a particular country, such as the United
  • the body of the oral product can have a variety of different shapes, some of which include disk, shield, rectangle, and square. According to certain embodiments, the body can have a length or width of between 5 mm and 25 mm and a thickness of between 1 mm and 10 mm.
  • the oral product's body can be compressible and springy.
  • the body has a compressibility @ 250 N of less than 95%, less than 90%, less than 85%, or less than 80%.
  • the body has a compressibility of @ 250 N of between 45% and 90%.
  • the oral product's body can have a compressibility @ 425 N of less than 99%.
  • the body can have a compressibility @ 425 N of between 60% and 98%.
  • the body can also have a percentage of springiness of at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, or at least 75%.
  • the body can have a percentage of springiness of between 75% and 90%.
  • the oral product can include a combination of soluble fibers and insoluble cellulosic fibers.
  • a ratio of soluble fiber to cellulosic fibers can be between 1:60 and 60:1.
  • the soluble fibers can include maltodextrin.
  • the soluble fibers comprise starch.
  • the soluble fibers can be derived from corn.
  • Another aspect of the subject matter described in this specification is methods of making and using the oral product. The methods of making the oral product can include the actions of extruding a mouth-stable polymer having cellulosic fibers and/or one or more additives dispersed therein.
  • FIG. 1 is a perspective view of a pair of oral products.
  • FIGS. 2A-2M illustrate various exemplary shapes of oral products.
  • FIGS. 3A and 3B illustrate oral products including surface features.
  • FIG. 4 illustrates a cross-section of a hypothetical oral product.
  • FIG. 5A illustrates a process diagram for making oral products according to some embodiments.
  • FIG. 5B illustrates an extruder configuration for making oral products according to some embodiments.
  • FIG. 6A illustrates a process diagram for making oral products according to other embodiments.
  • FIG. 6B illustrates an extruder configuration for making oral products according to certain embodiments
  • FIG. 7 illustrates a rod of mouth-stable polymer exiting an extruder die.
  • FIG. 8 illustrates how a cut piece of mouth-stable polymer including fibers and/or additives can pillow.
  • the oral products described herein include a mouth-stable polymer matrix and one or more additives.
  • the one or more additives can be dispersed in the mouth-stable polymer matrix such that the one or more additives are released from the oral product when the oral product is received within the oral cavity and exposed to saliva.
  • the oral products described herein can provide a favorable additive release profile and tactile experience.
  • Suitable mouth-stable polymers include thermoplastic elastomers such as polyurethane.
  • mouth stable means that the polymer does not appreciably dissolve or disintegrate when exposed to saliva within an oral cavity and at the normal human body temperature (e.g., about 98.6° F.) over a period of one hour.
  • mouth-stable polymers can include biodegradable polymers that breakdown over periods of days, weeks, months, and/or years, but do not appreciably break down when held in an oral cavity and exposed to saliva for a period of one hour.
  • the mouth-stable polymer is stable within an oral cavity and exposed to saliva at the normal human body temperature for a period of at least 6 hours, at least 12 hours, at least 24 hours, or at least 2 days. Accordingly, the oral products described herein can remain intact when placed within an oral cavity during a use period. After use, the mouth-stable polymer matrix can be removed from the oral cavity and discarded.
  • the mouth-stable polymer can have shape stability.
  • the oral product 110 can be chewed without significant and instantaneous permanent plastic deformation. As the oral product 100 is chewed, it can become more pliable and additional additives can become available for release into the oral cavity. Some embodiments of the oral product 110 can be adapted to remain non-sticky during and after use. After prolonged use, certain embodiments of the oral product 110 will expand and become flatter. The oral product, however, can retain the essence of its original shape.
  • One or more additives are included in the oral product and adapted to be released from the oral product when the oral product is placed in an oral cavity.
  • the oral product can also include fibers, fillers, plasticizers, and/or processing aids. Fibers can help to provide access to the additives, sweeteners, and/or flavorants. As will be discussed below, fibers can provide channels for additives, sweeteners, and/or flavorants to leach out of the mouth-stable polymer matrix.
  • the fiber-polymer matrix can absorb one or more additives and provide a pathway for one or more additives to be released from the oral product.
  • the fiber-polymer matrix can be porous.
  • the fiber-polymer matrix can have a plurality of pores having a pore diameter of between 40 microns and 60 microns and a plurality of pores having a pore diameter of between 1 micron and 10 microns.
  • saliva can be absorbed into the fiber-polymer matrix to release the additives, sweeteners, and/or flavorants.
  • the absorbed saliva can enter the pores and/or cause the fibers to expand, which can facilitate further release of additives, sweeteners, and/or flavorants.
  • Mechanical action e.g., chewing
  • the oral product can facilitate the release of the additives, sweeteners, and/or flavorants.
  • Fillers can also be included in the mouth-stable polymer matrix to alter the texture or pliability of the oral product.
  • the mouth-stable polymer matrix can also include plasticizers, which can increase the softness of the oral product.
  • Processing aids can also be present in the oral product and be used to facilitate shaping processes.
  • FIG. 1 depicts an example of an oral product 110 .
  • the oral product 110 has a disk shape.
  • the oral product 110 can have a diameter of about 12 mm and a thickness of about 2.5 mm.
  • the oral product 110 can be molded into any desired shape.
  • the oral product 110 A-L can be formed in a shape that promotes improved oral positioning in the oral cavity, improved packaging characteristics, or both.
  • the oral product 110 A-L can be configured to be: (A) an elliptical-shaped oral product 110 A; (B) an elongated elliptical-shaped oral product 110 B; (C) semi-circular oral product 110 C; (D) square or rectangular-shaped oral product 110 D; (E) football-shaped oral product 110 E; (F) elongated rectangular-shaped oral product 110 F; (G) boomerang-shaped oral product 110 G; (H) rounded-edge rectangular-shaped oral product 110 H; (I) teardrop- or comma-shaped oral product 110 I; (J) bowtie-shaped oral product 110 J; (K) peanut-shaped oral product 110 K; and (L) shield-shaped oral product.
  • the oral product can have different thicknesses or dimensionality, such that a beveled article (e.g., a wedge) is produced (see, for example, product 110 M depicted in FIG. 2M ) or a hemi-spherical shape is produced.
  • the oral product has a shield shape.
  • flavorants can be included on an exterior of the oral product 110 .
  • an oral product 120 A can be equipped with flavor strips 116 .
  • the oral product 110 can be embossed or stamped with a design (e.g., a logo, an image, or the like).
  • the oral product 120 B can be embossed or stamped with any type of design 117 including, but not limited to, a trademark, a product name, or any type of image.
  • the design 117 can be formed directly into the oral product, arranged along the exterior of the product 120 B.
  • the design 117 can also be embossed or stamped into those embodiments with a dissolvable film 116 applied thereto.
  • the oral product 110 or products 110 A-M can be wrapped or coated in an edible or dissolvable film, which may be opaque, substantially transparent or translucent.
  • the dissolvable film can readily dissipate when the oral product 110 is placed in an oral cavity.
  • the oral product 110 can be coated with a mouth-stable material.
  • Exemplary coating materials include Beeswax, gelatin, acetylated monoglyceride, starch (e.g., native potato starch, high amylose starch, hydroxypropylated potato starch), Zein, Shellac, ethyl cellulose, methylcellulose, hydroxypropyl methylcellulose, carboxymethyl cellulose, and combinations thereof.
  • a coating can include a combination of gelatin and methylcellulose.
  • a coating material can include a plasticizer.
  • a coating can include a colorant, a flavorant, and/or a one or more of the additives discussed above.
  • a coating can include caffeine to provide a user with an initial caffeine burst.
  • the matrix of mouth-stable polymer 120 can have surfaces roughened to improve the adherence of a coating.
  • a coating can provide a glossy or semi-glossy appearance, a smooth surface, and/or an appealing visual aesthetic (e.g., a nice color).
  • the coating e.g., a beeswax, Zein, acetylated monoglyceride, and/or hydroxypropylated potato starch coating
  • the coating can provide soft mouth feel.
  • the coating e.g., a methylcellulose, hydroxypropyl methylcellulose, carboxymethyl cellulose, ethyl cellulose, and/or gelatin coating
  • One or more oral products 110 can be packaged in a variety of conventional and non-conventional manners.
  • a plurality of oral products 110 can be packaged in a container having a lid.
  • a plurality of oral products 110 can be stacked and packaged in a paper, plastic, and/or aluminum foil tube.
  • the packaging can have a child-resistant lid.
  • the oral product 110 can also include additional elements.
  • a mouth-stable polymer matrix including one or more additives can be attached to a rod, tube, or stick.
  • the fiber-polymer matrix could be positioned on a stick to form a lollipop type structure.
  • the coating could be formed on a stick.
  • the oral product 110 can provide a favorable tactile experience (e.g., mouth feel).
  • the oral product 110 can also retain its shape during processing, shipping, handling, and optionally use.
  • the oral product 110 includes a mouth-stable polymer matrix that does not appreciably dissolve or disintegrate when placed in an oral cavity and exposed to saliva.
  • the oral product 110 can have an elasticity allowing a consumer to work the product within the mouth.
  • the oral product 110 has at least some shape memory and thus can return to shape after being squeezed between teeth in an oral cavity. Working of the oral product 110 within the oral cavity can accelerate the release of the additives, sweeteners, and/or flavorants within the mouth-stable polymer matrix.
  • the oral product 110 can absorb saliva into the polymer-fiber matrix.
  • the saliva can cause the polymer-fiber matrix to swell, which can further increase access to different sections of the polymer-fiber matrix.
  • Physical activity such as chewing of the product in the mouth, can also accelerate the polymer-matrix swelling and therefore the release of additives.
  • saliva can access different sections of the polymer-fiber matrix.
  • the mouth-stable polymer can have shape stability.
  • the oral product 110 can be chewed without significant and instantaneous permanent plastic deformation (such as that experienced by a chewing gum when chewed). As the oral product 110 is chewed, it can become more pliable and additional additives can become available for release into the oral cavity.
  • Some embodiments of the oral product 110 can be adapted to remain non-sticky during and after use. After prolonged use, certain embodiments of the oral product 110 will expand and become flatter. The oral product, however, can retain the essence of its original shape. The amount of deformation will depend on the duration of use and an amount of mouth force used. As the product is used, it can increase in both weight and volume, due to the swelling. With greater the physical manipulation, the oral product 110 will have a greater amount of swelling and thus have a larger weight gain. In certain embodiments, the oral product 110 will have an increase in weight of between 4 and 75 percent when chewed by a consumer for 30 minutes.
  • compression @ 250 N test defines a test of a sample where the sample is placed on a flat stationary surface and twice compressed with a 10 mm-diameter-sphere-tipped probe with a force of 250 N with a hold time of 30 seconds between compressions.
  • the “percentage of compression @ 250 N” is the maximum amount of reduction in thickness of the sample during the compression @ 250 N test.
  • compression @ 425 N test defines a test of a sample where the sample is placed on a flat stationary surface and twice compressed with a 10 mm-diameter-sphere-tipped probe with a force of 425 N with a hold time of 30 seconds between compressions.
  • a normal human bite force is typically between 400 and 500 N.
  • the oral product 110 has a percentage of compression @ 250 N of less than 95%. In certain embodiments, the oral product 110 has a percentage of compression @ 250 N of less than 90%, less than 85%, or less than 80%. In certain embodiments, the oral product 110 has a percentage of compression @ 250 N of at least 10%, at least 25%, or at least 40%. For example, the oral product can have a percentage of compression @ 250 N of between 45% and 80%. In some embodiments, the oral product 110 has a percentage of compression @ 425 N of less than 99%. In certain embodiments, the oral product 110 has a percentage of compression @ 425 N of less than 98%, less than 97%, or less than 96%. In certain embodiments, the oral product 110 has a percentage of compression @ 425 N of at least 10%, at least 25%, at least 50%, or at least 60%. For example, the oral product can have a percentage of compression @ 425 N of between 65% and 98%.
  • the springiness of a sample can be measured by measuring the percenage of recovery after a sample is compressed.
  • the term “percentage of springiness” means the percentage of thickness recovery of the sample during a 30 second recovery time after being compressed by the compression @ 425 N test using the 10 mm-diameter-sphere-tipped probe. For example, if a sample is compressed from an original thickness of 3.0 mm to a thickness of 2.0 mm and then recovers to 2.5 mm after 30 seconds, the springiness of the sample would be 50%.
  • the oral product 110 has a percentage of springiness of at least 20%.
  • the oral product 110 has a percentage of springiness of at least 40%, at least 50%, at least 60%, at least 70%, at least 75%, or at least 80%. In certain embodiments, the percentage of springiness is less than 95%, less than 90%, or less than 87%. For example, the oral product can have a percentage of springiness of between 75% and 90%.
  • the particular materials used in the oral product 110 and the processing techniques discussed below can have an impact on the compressibility and springiness of the oral product.
  • the incorporation of air bubbles or channels, or different fillers and/or fibers can also have an impact on the elasticity and pliability of the oral product.
  • the material properties of the overall oral product 110 can change as additives are released.
  • fibers and/or fillers can also dissolve or disintegrate during use and thus alter the material properties of the oral product 110 during use.
  • the oral product 110 can have a variety of colors. In some embodiments, the oral product 110 has an off-white color. In other embodiments, natural and artificial coloring can be added to the mouth-stable polymer before or during the molding process to form oral products 110 having a predetermined color. Encapsulated flavors can be added during the extrusion process to create speckles, patterns or dots within the oral product.
  • the mouth-stable polymer can be a variety of different biocompatible and biostable polymers.
  • the mouth-stable polymer is a polymer generally recognized as safe by an appropriate regulatory agency.
  • the polymer is a thermoplastic polymer.
  • the polymer can also be a thermoplastic elastomer.
  • suitable mouth-stable polymers include polyurethanes, silicon polymers, polyesters, polyacrylates, polyethylenes, polypropylenes, polyetheramides, polystyrenes (e.g., acrylonitrile butadiene styrene, high impact polystyrenes (HIPS)) polyvinyl alcohols, polyvinyl acetates, polyvinyl chlorides, polybutyl acetates, butyl rubbers (e.g., polyisobutylenes), SEBS, SBS, SIS, and mixtures and copolymers thereof.
  • the mouth-stable polymer is food-grade or medical-grade polymers (e.g., medical-grade polyurethane).
  • the mouth-stable polymer forms the mouth-stable polymer matrix of the oral product 110 .
  • the oral product includes at least 10 weight percent of one or more mouth-stable polymers.
  • the oral product includes at least 20 weight percent, at least 30 weight percent, at least 40 weight percent, at least 50 weight percent, at least 60 weight percent, at least 70 weight percent, at least 80 weight percent, or at least 90 weight percent of one or more mouth-stable polymers.
  • the oral product includes between 10 and 90 weight percent of one or more mouth-stable polymers. Accordingly to some embodiments, the oral product includes between 40 and 80 weight percent of the mouth-stable polymers. Some embodiments of the oral product have between 55 and 70 weight percent polymers.
  • the mouth-stable polymer has a flexural modulus of at least 5 MPa when tested according to ASTM Testing Method D790 or ISO 178 at 23 degrees Celsius.
  • the flexural modulus is at least 10 MPa.
  • the flexural modulus can be between 10 MPa and 30 MPa.
  • the mouth-stable polymer is a grade that complies with food-contact regulations applicable in one or more countries (e.g., US FDA regulations).
  • the mouth-stable polymer can be a polyurethane, SIS, or other thermal plastic elastomer meeting the requirements of the FDA-modified ISO 10993, Part 1 “Biological Evaluation of Medical Devices” tests with human tissue contact time of 30 days or less.
  • the mouth-stable polymer can have a shore Hardness of 50 D or softer, a melt flow index of 3 g/10 min at 200° C./10 kg, a tensile strength of 10 MPa or more (using ISO 37), and a ultimate elongation of less than 100% (using ISO 37).
  • the additives can include alkaloids (e.g., caffeine), minerals, vitamins, dietary supplements, nutraceuticals, energizing agents, soothing agents, coloring agents, amino acids, chemsthetic agent, antioxidants, food grade emulsifiers, pH modifiers, botanicals (e.g., green tea), teeth whitening (e.g., SHRIMP), therapeutic agents, sweeteners, flavorants, and combinations thereof.
  • alkaloids e.g., caffeine
  • minerals e.g., minerals
  • nutraceuticals e.g., nutraceuticals, energizing agents
  • soothing agents coloring agents, amino acids, chemsthetic agent, antioxidants, food grade emulsifiers, pH modifiers, botanicals (e.g., green tea), teeth whitening (e.g., SHRIMP), therapeutic agents, sweeteners, flavorants, and combinations thereof.
  • a soothing agent provides a soothing sensation to the throat and oral cavity.
  • Suitable soothing agents include, without limitation, chamomile, lavender
  • Energizing ingredients or vitamins include, without limitation, caffeine, taurine, guarana, vitamin B6, vitamin B12, and the like.
  • the oral product 110 includes caffeine.
  • a caffeinated oral product can include synthetic caffeine and/or coffee-bean-extracted caffeine.
  • a caffeinated oral product includes coffee flavors and sweeteners.
  • the fibers in a caffeinated oral product are coffee bean fibers.
  • an oral product can include between 10 and 200 mg of caffeine.
  • Oral products 110 can also include vitamins, dietary minerals, other dietary supplements, and/or therapeutic agents.
  • suitable vitamins include vitamins A, B1, B2, B6, C, D2, D3, E, F, K, and P.
  • an oral product 110 can include C-vitamins with or without the presence of caffeine.
  • Suitable dietary minerals include calcium (as carbonate, citrate, etc.) or magnesium (as oxide, etc.), chromium (usually as picolinate), and iron (as bis-glycinate).
  • One or more dietary minerals could be included in an oral product with or without the use of other additives.
  • Other dietary supplements and/or therapeutic agents can also be included as additives.
  • the oral product 110 includes a therapeutic agent that is preferable absorbed transbuccally.
  • therapeutic agents that can be included in an oral product 110 provided herein can include Gerd, Buprenorphin, Nitroglycerin, Diclofenac, Fentanyl, Carbamazepine, Galantamine, Acyclovir, Polyamidoamine Nanoparticles, Chlorpheniramine, Testosterone, Estradiol, Progesterone, Calcitonin, Fluorouracil, Naltrexone, Odansetron, Decitabine, Selegiline, Lamotrigine, and Prochlorperazine.
  • an oral product 110 can include Buprenorphine and be used for pain treatment.
  • an oral product 110 can include Nitroglycerin and be used for Angina Pectoris treatment. Because of the release properties of the oral product 110 , therapeutic agents included therein can be released at a rate such that a majority of the therapeutic agent is absorbed transbuccally, rather than swallowed.
  • the oral product 110 can also include fillers such as starch, di-calcium phosphate, lactose, sorbitol, mannitol, and microcrystalline cellulose, calcium carbonate, dicalcium phosphate, calcium sulfate, clays, silica, glass particles, sodium lauryl sulfate (SLS), glyceryl palmitostearate, sodium benzoate, sodium stearyl fumarate, talc, and stearates (e.g., Mg or K), and waxes (e.g., glycerol monostearate, propylene glycol monostearate, and acetylated monoglycerides), stabilizers (e.g., ascorbic acid and monosterol citrate, BHT, or BHA), disintegrating agents (e.g., starch, sodium starch glycolate, cross caramellose, cross linked PVP), pH stabilizers, or preservatives.
  • fillers such as starch, di-calcium
  • the amount of filler in the oral product 110 is limited to less than 10 weight percent in sum. In some embodiments, the amount of filler in the oral product 110 is limited to be less than 5 weight percent in sum. In some embodiments, the fillers are mouth stable. In other embodiments, the fillers can dissolve or disintegrate during use and thus result in an oral product that becomes more pliable during use.
  • humectants can be added help maintain the moisture levels in the oral product 110 .
  • humectants include glycerin and propylene glycol.
  • anti-microbial agents can be added to prevent spoilage and to lengthen shelf-life.
  • Suitable natural sweeteners include sugars, for example, monosaccharides, disaccharides, and/or polysaccharide sugars, and/or mixtures of two or more sugars.
  • the oral product 110 includes one or more of the following: sucrose or table sugar; honey or a mixture of low molecular weight sugars not including sucrose; glucose or grape sugar or corn sugar or dextrose; molasses; corn sweetener; corn syrup or glucose syrup; fructose or fruit sugar; lactose or milk sugar; maltose or malt sugar or maltobiose; sorghum syrup; mannitol or manna sugar; sorbitol or d-sorbite or d-sobitol; fruit juice concentrate; and/or mixtures or blends of one or more of these ingredients.
  • the oral product 110 can also include non-nutritive sweeteners. Suitable non-nutritive sweeteners include: stevia, saccharin; Aspartame; sucralose; or acesulfame potassium.
  • the oral product 110 can optionally include one or more flavorants.
  • the flavorants can be natural or artificial.
  • Exemplary flavorants include, but are not limited to, berry flavors such as pomegranate, acai, raspberry, blueberry, strawberry, boysenberry, and/or cranberry.
  • flavorants include, without limitation, any natural or synthetic flavor or aroma, such as menthol, peppermint, spearmint, wintergreen, bourbon, scotch, whiskey, cognac, hydrangea, lavender, chocolate, licorice, citrus and other fruit flavors, such as apple, peach, pear, kiwi, cherry, plum, orange, lime, grape, lemon, kumquat, and grapefruit, gamma octalactone, vanillin, ethyl vanillin, breath freshener flavors, butter, rum, coconut, almond, pecan, walnut, hazelnut, French vanilla, macadamia, sugar cane, maple, cassis, caramel, banana, malt, espresso, kahlua, white chocolate, spice flavors such as cinnamon, clove, cilantro, basil, oregano, garlic, mustard, nutmeg, rosemary, thyme, tarragon, dill, sage, anise, and fennel, methyl salicylate,
  • the flavorants can include cocktail flavors, such as cosmopolitan, martini, margarita, manhattan, pina colada, daiquiri, bellini and the like.
  • Mint oils useful in particular embodiments of the oral product 110 include spearmint and peppermint.
  • Synthetic flavorants can also be used.
  • the particular combination of flavorants can be selected from the flavorants that are generally recognized as safe (“GRAS”) in a particular country, such as the United States.
  • Flavorants can also be included in the oral product as encapsulated flavorants.
  • the flavorants in the oral product 110 are limited to less than 20 weight percent in sum.
  • the flavorants in the oral product 110 are limited to be less than 10 weight percent in sum.
  • certain flavorants can be included in the oral product 110 in amounts of about 1 weight percent to 5 weight percent.
  • the oral product can include fibers within the mouth-stable polymer matrix.
  • FIG. 4 depicts an illustration of how a plurality of fibers 130 can be dispersed in a mouth-stable polymer matrix 120 .
  • the fibers can be mixed with the mouth-stable polymer prior to or during an extrusion process.
  • the fibers provide passages in the mouth-stable polymer matrix, which can permit certain additives within the mouth-stable polymer matrix to be released into an oral cavity when the oral product is received in an oral cavity and exposed to saliva.
  • the additives can be absorbed in fiber-polymer matrix and/or form pockets within the mouth-stable polymer matrix, which can be accessed via the fibers 130 .
  • the oral product 110 can also include channels 135 formed adjacent the fibers 130 .
  • the fibers are hydrophilic such that water-soluble additives can be wicked by the fibers.
  • the fibers can dissolve to leave channels.
  • Additives 140 can be present in the mouth-stable polymer matrix 120 .
  • the fibers can be cellulosic fibers.
  • the cellulosic fibers can be derived from plant tissue.
  • the cellulosic fibers includes cellulose.
  • the cellulosic fibers can further include lignin and/or lipids. Suitable sources for cellulosic fibers include wood pulp, cotton, sugar beets, bran, citrus pulp fiber, switch grass and other grasses, Salix (willow), tea, and Populus (poplar).
  • the cellulosic fibers can be plant tissue comprising various natural flavors, sweeteners, or active ingredients. For example, coffee beans can be ground into fibers and incorporated into the mouth-stable polymer matrix to provide a fibrous structure, flavor, and caffeine.
  • the cellulosic fibers can have a variety of dimensions.
  • the dimensions of the fibers (in addition to the amount) can impact the release characteristics of the additives.
  • cellulosic fibers can be hydrophilic, thus water soluble additives (e.g., caffeine) can preferentially be absorbed in fiber-polymer matrix.
  • the release profile of the additive from a polyurethane oral product 110 can be impacted by both the fiber sizes and the amounts of fiber.
  • the cellulosic fiber can be processed to have an average fiber size of less than 200 micrometers.
  • the fibers are between 75 and 125 micrometers. In other embodiments, the fibers are processed to have a size of 75 micrometers or less.
  • the oral product 110 can also include soluble fibers.
  • the soluble fibers can be adapted to dissolve when exposed to saliva when the oral product 110 is received in an oral cavity.
  • Soluble fibers can be used alone or with cellulosic fibers to provide channels 135 for additives 140 and/or 142 to be released from the oral product 110 .
  • Suitable soluble fibers include psyllium fibers.
  • the fibers can be partially soluble. For example, sugar beet fibers can partially dissolve during use.
  • an oral product 110 can include a combination of soluble and insoluble fibers.
  • the ratio of soluble to insoluble fiber can impact the softness of texture of the oral product 110 .
  • the ratio of soluble to insoluble fiber can also impact the compressibility of the oral product 110 .
  • a ratio of soluble to insoluble fiber is between 1:60 and 60:1.
  • the ratio of soluble to insoluble fiber is greater than 1:50, greater than 1:40, greater than 1:30, greater than 1:20, greater than 1:10, or greater than 1:5.
  • the ratio of soluble to insoluble fiber is less than 1:1, less than 1:2, less than 1:5, less than 1:10, less than 1:20, or less that 1:30.
  • an oral product having a mixture of soluble and insoluble fibers can have a percentage of compression @ 250 N of between 60 percent and 98 percent, between 65 percent and 95 percent, between 70 percent and 90 percent, or between 80 and 89 percent.
  • soluble fiber can increase the compressibility of the oral product, which can also be perceived as a softer mouth feel by a consumer.
  • the soluble and the insoluble fiber can be pre-mixed and added into the process via a single feeder. Separate fiber feeders can also be used to produce a desired ratio. In some cases, the inclusion of about 1-3% of soluble fiber and about 25-35% insoluble fiber can result in a Compression @250N of between 70% and 90%.
  • the oral product 110 can also include one or more plasticizers.
  • Plasticizers can soften the final oral product and thus increase its flexibility. Plasticizers work by embedding themselves between the chains of polymers, spacing them apart (increasing the “free volume”), and thus significantly lowering the glass transition temperature for the plastic and making it softer.
  • Suitable plasticizers include propylene glycol, glycerin, vegetable oil, and medium chain triglycerides.
  • the plasticizer can include phthalates. Esters of polycarboxylic acids with linear or branched aliphatic alcohols of moderate chain length can also be used as plasticizers. Moreover, plasticizers can facilitate the extrusion processes described below.
  • the oral product 110 can include up to 20 weight percent plasticizer. In some embodiments, the oral product 110 includes between 0.5 and 10 weight percent plasticizer, the oral product 110 can include between 1 and 8 weight percent plasticizer, or between 2 and 4 weight percent plasticizer.
  • the oral product 110 can be produced by extruding a mouth-stable polymer (e.g., polyurethane) with fibers (e.g., cellulosic fiber) and/or additive (e.g., caffeine) to form a rod of a mouth-stable polymer matrix including fibers and/or additives.
  • a mouth-stable polymer e.g., polyurethane
  • fibers e.g., cellulosic fiber
  • additive e.g., caffeine
  • a mouth-stable polymer 510 e.g., polyurethane
  • fibers 512 e.g., cellulosic fibers
  • the fibers 512 can be passed through a sieve 514 prior to introduction into the extruder.
  • a mixture of additives 516 can also be introduced into the extruder.
  • the mixture of additives 516 can be a solution (as shown).
  • the additives can include a plasticizer 517 (e.g., propylene glycol) and a sweetener 518 (e.g., sucralose).
  • the mixture of additives can also be provided in slurry form or a dry mix of powdered additives.
  • FIG. 5B illustrates an example of how the mouth-stable polymer 510 (e.g., polyurethane) can be compounded with fiber 512 and a mixture of additives 516 .
  • polyurethane pellets 510 and cellulosic fibers 512 can be introduced into an infeed section of an extruder.
  • a first section of the extruder melts and mixes the polymer, elevating the temperature to about 150° C.
  • the mixture 516 of propylene glycol 517 and sucralose 518 can be injected into the extruder downstream of the infeed section of the extruder.
  • the polymer/fiber/plasticizer/sweetener mixture can then be extruded out of an extrusion die 720 at a temperature of about 150° C.
  • An example of an extrusion die is shown in FIG. 7 .
  • the extruder of FIG. 5B can operate at a mass flow rate of about 1.8 lbs/hour.
  • the polymer-fiber combination can exit an extrusion die 720 as a rod 710 and onto a moving conveyor 730 , as shown in FIG. 7 .
  • the size of the extrusion die 720 , the take away speed of the moving conveyor 730 , the mixture of polymer-fiber combination, and the temperature of the mixture exiting the die 720 can all have an impact on the final diameter of the rod 710 .
  • the extruded polymer-fiber rod 710 is then cut in a cutting process 530 , as shown in FIG. 5A .
  • the cutting can be hot-face cutting. Hot-face cutting can occur immediately after the rod 720 exits the extrusion die 720 .
  • the cutting can induce pillowing of the polymer matrix, as shown in FIG. 8 .
  • the cutting process 530 can also include a process of rounding the edges of the cut polymer-fiber composite.
  • a pelletizer can be used to round the edges.
  • the pelletizer can also help to cool the oral products 110 .
  • the extruded polymer-fiber rod 710 is cooled prior to cutting.
  • additives and/or flavorants can be added to the extruded polymer-fiber rod and/or pieces.
  • a mixture of additives 550 and a mixture of flavorants 560 can be absorbed into polymer-fiber pieces in one or more absorbing processes 540 .
  • the mixture of additives 550 can include active 552 (e.g., caffeine) and water 554 .
  • a mixture of flavorants 560 can include a flavor 562 (e.g., wintergreen) and a carrier 564 (e.g., ethanol).
  • the oral products 110 could then be dried, packaged, and sealed.
  • FIG. 6A depicts an alternative arrangement where a mouth-stable polymer 510 (e.g., polyurethane) is compounded with a mixture 516 of one or more plasticizers 517 (e.g., propylene glycol) and/or sweeteners 518 (e.g., sucralose) in a first extrusion process 622 .
  • the compounded polymer/plasticizer/sweetener mixture is then compounded with fiber 512 in a second extrusion process 624 .
  • additives such as active 552 (e.g., caffeine) and/or flavorants 562 can also be added during the second extrusion process 624 .
  • the compounding in the first extrusion process occurs at a higher temperature than the compounding during the second extrusion process. Both extrusion processes can occur in a single extruder.
  • FIG. 6B depicts an arrangement of an extruder where the active, plasticizer, fibers and flavorants are all added the mouth-stable polymer in the extruder.
  • Polyurethane pellets 510 are added to an infeed section 610 of the extruder 620 .
  • Plasticizer 517 e.g., propylene glycol
  • a vent 640 can be provided to release volatiles.
  • Cellulosic fibers 512 can be introduced into the extruder through a side feeder 630 .
  • a flavorant mixture 560 can be added through liquid injector 660 in a flavor mixing section of the extruder.
  • Active 52 e.g., caffeine
  • plasticizer 517 can also be injected through liquid injector 660 .
  • the mixture can then be extruded through an extrusion die 720 at a temperature of about 165° C.
  • the extruded mixture can be hot-cut as it exits the extrusion die 720 and passed to a pelletizer.
  • the extruded mixture can be cooled on a cooling conveyer and cut.
  • the extruder of FIG. 6B can operate at a mass flow rate of about 5.5 lbs/hour.
  • the oral products 110 can be further flavored in a pan coater.
  • the oral products 110 can then be sent to bulk storage and packaged.
  • extruded and cut pieces can be introduced into a compression mold to form a final oral product shape.
  • the oral product 110 can be injection molded, compression molded, or injection-compression molded. Blocks of polymer, fiber, and/or additive can also be formed and machined into a desired shape.

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a mouth-stable polymer matrix, cellulosic fibers embedded in the mouth-stable polymer matrix, and an additive dispersed in the mouth-stable polymer matrix. The oral product is adapted to release the additive from the body when the body is received within the oral cavity and exposed to saliva.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 15/850,494, filed Dec. 21, 2017, which is a divisional of U.S. application Ser. No. 13/744,905, filed Jan. 18, 2013, which claims priority to U.S. Provisional Application Ser. No. 61/588,861 filed Jan. 20, 2012, the entire contents of each of which are incorporated herein by reference.
  • TECHNICAL FIELD
  • This document relates to oral products including mouth-stable polymers and one or more additives.
  • BACKGROUND
  • Oral products providing flavor and/or one or more active ingredients are well known. One such oral product is chewing gum. Other oral products include hard candies (e.g., mints). Softer gelatin-based oral products are also known. Pharmaceutical and therapeutic products (e.g., cough-suppressant lozenges) can also be provided in a solid form for oral consumption. The flavor release and/or active agent release characteristics for an oral product are important for providing an improved consumer product.
  • SUMMARY
  • This specification describes an oral product that provides a satisfying tactile and/or flavor experience. In particular embodiments, the oral product can provide an extended additive release time. The oral product includes a body that is at least partially receivable in an oral cavity of a consumer. In some embodiments, the body includes a mouth-stable polymer matrix, cellulosic fibers embedded in the stable polymer matrix, and one or more additives dispersed in the body such that it is released when the body is received within the oral cavity and exposed to saliva.
  • The oral product, according to certain embodiments, includes flavorants, sweeteners, vitamins, minerals, therapeutic agents, nutraceuticals, energizing agents, soothing agents, coloring agents, amino acids, chemsthetic agents, antioxidants, food grade emulsifiers, pH modifiers, botanicals, teeth whitening agents, and/or alkaloids (e.g., caffeine). Combinations of additives (e.g., sweeteners, flavorants, and caffeine) can be combined to provide a favorable tactile and flavor experience.
  • These and other embodiments can each optionally include one or more of the following features. In some embodiments, the oral product's body includes at least 10 weight percent of the mouth-stable polymer. The mouth-stable polymer matrix can include polyurethane, silicon polymer, polyester, polyacrylate, polyethylene, poly(styrene-ethylene-butylene-styrene) (“SEBS”), poly(styrene-butadiene-styrene) (“SBS”), poly(styrene-isoprene-styrene)(“SIS”), and other similar thermoplastic elastomers, or any copolymer, mixture, or combination thereof. The oral product can also include a plasticizer dispersed in the mouth-stable polymer matrix. For example, the plasticizer can be propylene glycol, glycerin, vegetable oil, triglycerides, or a combination thereof. The oral product can also include a sweetener dispersed in the body. The sweetener can be saccharine, sucralose, aspartame, acesulfame potassium, or a combination thereof.
  • The oral product, according to certain embodiments, can include an additive selected from the group consisting of minerals, vitamins, dietary supplements, nutraceuticals, energizing agents, soothing agents, amino acids, chemsthetic agents, antioxidants, botanicals, teeth whitening agents, therapeutic agents, or a combination thereof. The additives can be absorbed into the cellulosic fibers and polymer matrix.
  • The oral product's body can have at least 10 weight percent cellulosic fibers. The cellulosic fibers can be derived from plant tissue. In some embodiments, the cellulosic fibers include cellulose. The cellulosic fibers can further include lignin and/or lipids. For example, the cellulosic fibers can be selected from the following: sugar beet fiber, wood pulp fiber, cotton fiber, bran fiber, citrus pulp fiber, grass fiber, willow fiber, poplar fiber, and combinations thereof. The cellulosic fibers may also be chemically treated prior to use. For example, the cellulosic fibers can be CMC, HPMC, HPC, or other treated cellulosic material.
  • The oral product can include flavorants. The flavorants can be natural or artificial. Flavorants can be selected from the following: licorice, wintergreen, cherry and berry type flavorants, Drambuie, bourbon, scotch, whiskey, spearmint, peppermint, lavender, cinnamon, cardamon, apium graveolents, clove, cascarilla, nutmeg, sandalwood, bergamot, geranium, honey essence, rose oil, vanilla, lemon oil, orange oil, Japanese mint, cassia, caraway, cognac, jasmin, chamomile, menthol, ylang ylang, sage, fennel, pimenta, ginger, anise, coriander, coffee, mint oils from a species of the genus Mentha, cocoa, and combinations thereof. Synthetic flavorants can also be used. The particular combination of flavorants can be selected from the flavorants that are generally recognized as safe (“GRAS”) in a particular country, such as the United States. Flavorants can also be included in the oral product as encapsulated flavorants.
  • The body of the oral product can have a variety of different shapes, some of which include disk, shield, rectangle, and square. According to certain embodiments, the body can have a length or width of between 5 mm and 25 mm and a thickness of between 1 mm and 10 mm.
  • The oral product's body can be compressible and springy. In some embodiments, the body has a compressibility @ 250 N of less than 95%, less than 90%, less than 85%, or less than 80%. In some embodiments, the body has a compressibility of @ 250 N of between 45% and 90%. The oral product's body can have a compressibility @ 425 N of less than 99%. For example, the body can have a compressibility @ 425 N of between 60% and 98%. The body can also have a percentage of springiness of at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, or at least 75%. For example, the body can have a percentage of springiness of between 75% and 90%.
  • The oral product can include a combination of soluble fibers and insoluble cellulosic fibers. In some embodiments, a ratio of soluble fiber to cellulosic fibers can be between 1:60 and 60:1. In some embodiments, the soluble fibers can include maltodextrin. In some embodiments, the soluble fibers comprise starch. The soluble fibers can be derived from corn. In general, another aspect of the subject matter described in this specification is methods of making and using the oral product. The methods of making the oral product can include the actions of extruding a mouth-stable polymer having cellulosic fibers and/or one or more additives dispersed therein.
  • The details of one or more embodiments of the subject matter described in this specification are set forth in the accompanying drawings and the description below. Other features, aspects, and advantages of the subject matter will become apparent from the description, the drawings, and the claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a pair of oral products.
  • FIGS. 2A-2M illustrate various exemplary shapes of oral products.
  • FIGS. 3A and 3B illustrate oral products including surface features.
  • FIG. 4 illustrates a cross-section of a hypothetical oral product.
  • FIG. 5A illustrates a process diagram for making oral products according to some embodiments.
  • FIG. 5B illustrates an extruder configuration for making oral products according to some embodiments.
  • FIG. 6A illustrates a process diagram for making oral products according to other embodiments.
  • FIG. 6B illustrates an extruder configuration for making oral products according to certain embodiments
  • FIG. 7 illustrates a rod of mouth-stable polymer exiting an extruder die.
  • FIG. 8 illustrates how a cut piece of mouth-stable polymer including fibers and/or additives can pillow.
  • DETAILED DESCRIPTION
  • The oral products described herein include a mouth-stable polymer matrix and one or more additives. The one or more additives can be dispersed in the mouth-stable polymer matrix such that the one or more additives are released from the oral product when the oral product is received within the oral cavity and exposed to saliva. The oral products described herein can provide a favorable additive release profile and tactile experience.
  • Suitable mouth-stable polymers include thermoplastic elastomers such as polyurethane. As used here, the term “mouth stable” means that the polymer does not appreciably dissolve or disintegrate when exposed to saliva within an oral cavity and at the normal human body temperature (e.g., about 98.6° F.) over a period of one hour. In addition to biostable polymers, mouth-stable polymers can include biodegradable polymers that breakdown over periods of days, weeks, months, and/or years, but do not appreciably break down when held in an oral cavity and exposed to saliva for a period of one hour. In some embodiments, the mouth-stable polymer is stable within an oral cavity and exposed to saliva at the normal human body temperature for a period of at least 6 hours, at least 12 hours, at least 24 hours, or at least 2 days. Accordingly, the oral products described herein can remain intact when placed within an oral cavity during a use period. After use, the mouth-stable polymer matrix can be removed from the oral cavity and discarded.
  • The mouth-stable polymer can have shape stability. In some cases, the oral product 110 can be chewed without significant and instantaneous permanent plastic deformation. As the oral product 100 is chewed, it can become more pliable and additional additives can become available for release into the oral cavity. Some embodiments of the oral product 110 can be adapted to remain non-sticky during and after use. After prolonged use, certain embodiments of the oral product 110 will expand and become flatter. The oral product, however, can retain the essence of its original shape.
  • One or more additives are included in the oral product and adapted to be released from the oral product when the oral product is placed in an oral cavity.
  • In addition to additives, sweeteners, and flavorants, the oral product can also include fibers, fillers, plasticizers, and/or processing aids. Fibers can help to provide access to the additives, sweeteners, and/or flavorants. As will be discussed below, fibers can provide channels for additives, sweeteners, and/or flavorants to leach out of the mouth-stable polymer matrix. The fiber-polymer matrix can absorb one or more additives and provide a pathway for one or more additives to be released from the oral product. The fiber-polymer matrix can be porous. In some embodiments, the fiber-polymer matrix can have a plurality of pores having a pore diameter of between 40 microns and 60 microns and a plurality of pores having a pore diameter of between 1 micron and 10 microns. During use, saliva can be absorbed into the fiber-polymer matrix to release the additives, sweeteners, and/or flavorants. The absorbed saliva can enter the pores and/or cause the fibers to expand, which can facilitate further release of additives, sweeteners, and/or flavorants. Mechanical action (e.g., chewing) of the oral product can facilitate the release of the additives, sweeteners, and/or flavorants.
  • Fillers can also be included in the mouth-stable polymer matrix to alter the texture or pliability of the oral product. The mouth-stable polymer matrix can also include plasticizers, which can increase the softness of the oral product. Processing aids can also be present in the oral product and be used to facilitate shaping processes.
  • Oral Product Shapes and Packaging
  • FIG. 1 depicts an example of an oral product 110. The oral product 110 has a disk shape. For example, the oral product 110 can have a diameter of about 12 mm and a thickness of about 2.5 mm.
  • Referring now to FIGS. 2A-2M, the oral product 110 can be molded into any desired shape. For example, referring to FIGS. 2A-2L, the oral product 110A-L can be formed in a shape that promotes improved oral positioning in the oral cavity, improved packaging characteristics, or both. In some circumstances, the oral product 110A-L can be configured to be: (A) an elliptical-shaped oral product 110A; (B) an elongated elliptical-shaped oral product 110B; (C) semi-circular oral product 110C; (D) square or rectangular-shaped oral product 110D; (E) football-shaped oral product 110E; (F) elongated rectangular-shaped oral product 110F; (G) boomerang-shaped oral product 110G; (H) rounded-edge rectangular-shaped oral product 110H; (I) teardrop- or comma-shaped oral product 110I; (J) bowtie-shaped oral product 110J; (K) peanut-shaped oral product 110K; and (L) shield-shaped oral product. Alternatively, the oral product can have different thicknesses or dimensionality, such that a beveled article (e.g., a wedge) is produced (see, for example, product 110M depicted in FIG. 2M) or a hemi-spherical shape is produced. In some embodiments, the oral product has a shield shape.
  • In addition or in the alternative to flavorants being included within the mouth-stable polymer matrix, flavorants can be included on an exterior of the oral product 110. For example, referring to FIG. 3A, for example, some embodiments of an oral product 120A can be equipped with flavor strips 116.
  • Referring to FIG. 3B, particular embodiments of the oral product 110 can be embossed or stamped with a design (e.g., a logo, an image, or the like). For example, the oral product 120B can be embossed or stamped with any type of design 117 including, but not limited to, a trademark, a product name, or any type of image. The design 117 can be formed directly into the oral product, arranged along the exterior of the product 120B. The design 117 can also be embossed or stamped into those embodiments with a dissolvable film 116 applied thereto.
  • In some embodiments, the oral product 110 or products 110A-M can be wrapped or coated in an edible or dissolvable film, which may be opaque, substantially transparent or translucent. The dissolvable film can readily dissipate when the oral product 110 is placed in an oral cavity. In some embodiments, the oral product 110 can be coated with a mouth-stable material. Exemplary coating materials include Beeswax, gelatin, acetylated monoglyceride, starch (e.g., native potato starch, high amylose starch, hydroxypropylated potato starch), Zein, Shellac, ethyl cellulose, methylcellulose, hydroxypropyl methylcellulose, carboxymethyl cellulose, and combinations thereof. For example, a coating can include a combination of gelatin and methylcellulose. In some embodiments, a coating material can include a plasticizer. In some case, a coating can include a colorant, a flavorant, and/or a one or more of the additives discussed above. For example, a coating can include caffeine to provide a user with an initial caffeine burst. In some cases, the matrix of mouth-stable polymer 120 can have surfaces roughened to improve the adherence of a coating. In some cases, a coating can provide a glossy or semi-glossy appearance, a smooth surface, and/or an appealing visual aesthetic (e.g., a nice color). In some embodiments, the coating (e.g., a beeswax, Zein, acetylated monoglyceride, and/or hydroxypropylated potato starch coating) can provide soft mouth feel. In some embodiments, the coating (e.g., a methylcellulose, hydroxypropyl methylcellulose, carboxymethyl cellulose, ethyl cellulose, and/or gelatin coating) can provide a hard outer coating.
  • One or more oral products 110 can be packaged in a variety of conventional and non-conventional manners. For example, a plurality of oral products 110 can be packaged in a container having a lid. In other embodiments, a plurality of oral products 110 can be stacked and packaged in a paper, plastic, and/or aluminum foil tube. In some embodiments, such as for medications, the packaging can have a child-resistant lid.
  • The oral product 110 can also include additional elements. In some embodiments, a mouth-stable polymer matrix including one or more additives can be attached to a rod, tube, or stick. For example, the fiber-polymer matrix could be positioned on a stick to form a lollipop type structure. In other embodiments, the coating could be formed on a stick.
  • Oral Product Properties
  • The oral product 110 can provide a favorable tactile experience (e.g., mouth feel). The oral product 110 can also retain its shape during processing, shipping, handling, and optionally use. As noted above, the oral product 110 includes a mouth-stable polymer matrix that does not appreciably dissolve or disintegrate when placed in an oral cavity and exposed to saliva. In some embodiments, the oral product 110 can have an elasticity allowing a consumer to work the product within the mouth. In some embodiments, the oral product 110 has at least some shape memory and thus can return to shape after being squeezed between teeth in an oral cavity. Working of the oral product 110 within the oral cavity can accelerate the release of the additives, sweeteners, and/or flavorants within the mouth-stable polymer matrix.
  • During use, the oral product 110 can absorb saliva into the polymer-fiber matrix. The saliva can cause the polymer-fiber matrix to swell, which can further increase access to different sections of the polymer-fiber matrix. Physical activity, such as chewing of the product in the mouth, can also accelerate the polymer-matrix swelling and therefore the release of additives. As the product is chewed, saliva can access different sections of the polymer-fiber matrix. The mouth-stable polymer can have shape stability. In some cases, the oral product 110 can be chewed without significant and instantaneous permanent plastic deformation (such as that experienced by a chewing gum when chewed). As the oral product 110 is chewed, it can become more pliable and additional additives can become available for release into the oral cavity. Some embodiments of the oral product 110 can be adapted to remain non-sticky during and after use. After prolonged use, certain embodiments of the oral product 110 will expand and become flatter. The oral product, however, can retain the essence of its original shape. The amount of deformation will depend on the duration of use and an amount of mouth force used. As the product is used, it can increase in both weight and volume, due to the swelling. With greater the physical manipulation, the oral product 110 will have a greater amount of swelling and thus have a larger weight gain. In certain embodiments, the oral product 110 will have an increase in weight of between 4 and 75 percent when chewed by a consumer for 30 minutes.
  • One way of characterizing the properties of the oral product is by measuring the compressibility and springiness of the product. The compressibility can be calculated as a percentage of reduction in thickness of the sample when the sample is compressed with a standardized probe with a particular force. As used herein, the term “compression @ 250 N test” defines a test of a sample where the sample is placed on a flat stationary surface and twice compressed with a 10 mm-diameter-sphere-tipped probe with a force of 250 N with a hold time of 30 seconds between compressions. The “percentage of compression @ 250 N” is the maximum amount of reduction in thickness of the sample during the compression @ 250 N test. For example, if a 3 mm thick sample is compressed to a minimum thickness of 1.5 mm during either of the two compressions, the sample is said to have a 50% compression @ 250 N. As used herein, the term “compression @ 425 N test” defines a test of a sample where the sample is placed on a flat stationary surface and twice compressed with a 10 mm-diameter-sphere-tipped probe with a force of 425 N with a hold time of 30 seconds between compressions. For comparison, a normal human bite force is typically between 400 and 500 N.
  • In some embodiments, the oral product 110 has a percentage of compression @ 250 N of less than 95%. In certain embodiments, the oral product 110 has a percentage of compression @ 250 N of less than 90%, less than 85%, or less than 80%. In certain embodiments, the oral product 110 has a percentage of compression @ 250 N of at least 10%, at least 25%, or at least 40%. For example, the oral product can have a percentage of compression @ 250 N of between 45% and 80%. In some embodiments, the oral product 110 has a percentage of compression @ 425 N of less than 99%. In certain embodiments, the oral product 110 has a percentage of compression @ 425 N of less than 98%, less than 97%, or less than 96%. In certain embodiments, the oral product 110 has a percentage of compression @ 425 N of at least 10%, at least 25%, at least 50%, or at least 60%. For example, the oral product can have a percentage of compression @ 425 N of between 65% and 98%.
  • The springiness of a sample can be measured by measuring the percenage of recovery after a sample is compressed. As used herein, the term “percentage of springiness” means the percentage of thickness recovery of the sample during a 30 second recovery time after being compressed by the compression @ 425 N test using the 10 mm-diameter-sphere-tipped probe. For example, if a sample is compressed from an original thickness of 3.0 mm to a thickness of 2.0 mm and then recovers to 2.5 mm after 30 seconds, the springiness of the sample would be 50%. In some embodiments, the oral product 110 has a percentage of springiness of at least 20%. In certain embodiments, the oral product 110 has a percentage of springiness of at least 40%, at least 50%, at least 60%, at least 70%, at least 75%, or at least 80%. In certain embodiments, the percentage of springiness is less than 95%, less than 90%, or less than 87%. For example, the oral product can have a percentage of springiness of between 75% and 90%.
  • The particular materials used in the oral product 110 and the processing techniques discussed below can have an impact on the compressibility and springiness of the oral product. In addition to different materials have different compressibility and springiness properties, the incorporation of air bubbles or channels, or different fillers and/or fibers can also have an impact on the elasticity and pliability of the oral product. Additionally, the material properties of the overall oral product 110 can change as additives are released. In some embodiments, fibers and/or fillers can also dissolve or disintegrate during use and thus alter the material properties of the oral product 110 during use.
  • The oral product 110 can have a variety of colors. In some embodiments, the oral product 110 has an off-white color. In other embodiments, natural and artificial coloring can be added to the mouth-stable polymer before or during the molding process to form oral products 110 having a predetermined color. Encapsulated flavors can be added during the extrusion process to create speckles, patterns or dots within the oral product.
  • Polymers
  • The mouth-stable polymer can be a variety of different biocompatible and biostable polymers. In some embodiments, the mouth-stable polymer is a polymer generally recognized as safe by an appropriate regulatory agency. In some embodiments, the polymer is a thermoplastic polymer. The polymer can also be a thermoplastic elastomer. For example, suitable mouth-stable polymers include polyurethanes, silicon polymers, polyesters, polyacrylates, polyethylenes, polypropylenes, polyetheramides, polystyrenes (e.g., acrylonitrile butadiene styrene, high impact polystyrenes (HIPS)) polyvinyl alcohols, polyvinyl acetates, polyvinyl chlorides, polybutyl acetates, butyl rubbers (e.g., polyisobutylenes), SEBS, SBS, SIS, and mixtures and copolymers thereof. In certain embodiments, the mouth-stable polymer is food-grade or medical-grade polymers (e.g., medical-grade polyurethane).
  • The mouth-stable polymer forms the mouth-stable polymer matrix of the oral product 110. In some embodiments, the oral product includes at least 10 weight percent of one or more mouth-stable polymers. In certain embodiments, the oral product includes at least 20 weight percent, at least 30 weight percent, at least 40 weight percent, at least 50 weight percent, at least 60 weight percent, at least 70 weight percent, at least 80 weight percent, or at least 90 weight percent of one or more mouth-stable polymers. In certain embodiments, the oral product includes between 10 and 90 weight percent of one or more mouth-stable polymers. Accordingly to some embodiments, the oral product includes between 40 and 80 weight percent of the mouth-stable polymers. Some embodiments of the oral product have between 55 and 70 weight percent polymers.
  • The mouth-stable polymer according to certain embodiments has a flexural modulus of at least 5 MPa when tested according to ASTM Testing Method D790 or ISO 178 at 23 degrees Celsius. In some embodiments, the flexural modulus is at least 10 MPa. For example, the flexural modulus can be between 10 MPa and 30 MPa. In some embodiments, the mouth-stable polymer is a grade that complies with food-contact regulations applicable in one or more countries (e.g., US FDA regulations). In some embodiments, the mouth-stable polymer can be a polyurethane, SIS, or other thermal plastic elastomer meeting the requirements of the FDA-modified ISO 10993, Part 1 “Biological Evaluation of Medical Devices” tests with human tissue contact time of 30 days or less. The mouth-stable polymer can have a shore Hardness of 50 D or softer, a melt flow index of 3 g/10 min at 200° C./10 kg, a tensile strength of 10 MPa or more (using ISO 37), and a ultimate elongation of less than 100% (using ISO 37).
  • Additives
  • A variety of additives can be included in the oral product 110. The additives can include alkaloids (e.g., caffeine), minerals, vitamins, dietary supplements, nutraceuticals, energizing agents, soothing agents, coloring agents, amino acids, chemsthetic agent, antioxidants, food grade emulsifiers, pH modifiers, botanicals (e.g., green tea), teeth whitening (e.g., SHRIMP), therapeutic agents, sweeteners, flavorants, and combinations thereof. A soothing agent provides a soothing sensation to the throat and oral cavity. Suitable soothing agents include, without limitation, chamomile, lavender, jasmine, and the like. Suitable chemsthetic ingredients provide, without limitation, hot, spicy, or cooling flavors such as mint, menthol, cinnamon, pepper, and the like.
  • Energizing ingredients or vitamins include, without limitation, caffeine, taurine, guarana, vitamin B6, vitamin B12, and the like. According to certain embodiments, the oral product 110 includes caffeine. A caffeinated oral product can include synthetic caffeine and/or coffee-bean-extracted caffeine. In some embodiments, a caffeinated oral product includes coffee flavors and sweeteners. In some embodiments, the fibers in a caffeinated oral product are coffee bean fibers. According to some embodiments, an oral product can include between 10 and 200 mg of caffeine.
  • Oral products 110 can also include vitamins, dietary minerals, other dietary supplements, and/or therapeutic agents. For example, suitable vitamins include vitamins A, B1, B2, B6, C, D2, D3, E, F, K, and P. For example, an oral product 110 can include C-vitamins with or without the presence of caffeine. Suitable dietary minerals include calcium (as carbonate, citrate, etc.) or magnesium (as oxide, etc.), chromium (usually as picolinate), and iron (as bis-glycinate). One or more dietary minerals could be included in an oral product with or without the use of other additives. Other dietary supplements and/or therapeutic agents can also be included as additives.
  • In some embodiments, the oral product 110 includes a therapeutic agent that is preferable absorbed transbuccally. For example, so therapeutic agents do not pass into the blood stream if they are swallowed. Exemplary therapeutic agents that can be included in an oral product 110 provided herein can include Gerd, Buprenorphin, Nitroglycerin, Diclofenac, Fentanyl, Carbamazepine, Galantamine, Acyclovir, Polyamidoamine Nanoparticles, Chlorpheniramine, Testosterone, Estradiol, Progesterone, Calcitonin, Fluorouracil, Naltrexone, Odansetron, Decitabine, Selegiline, Lamotrigine, and Prochlorperazine. For example, an oral product 110 can include Buprenorphine and be used for pain treatment. In some embodiments, an oral product 110 can include Nitroglycerin and be used for Angina Pectoris treatment. Because of the release properties of the oral product 110, therapeutic agents included therein can be released at a rate such that a majority of the therapeutic agent is absorbed transbuccally, rather than swallowed.
  • The oral product 110 can also include fillers such as starch, di-calcium phosphate, lactose, sorbitol, mannitol, and microcrystalline cellulose, calcium carbonate, dicalcium phosphate, calcium sulfate, clays, silica, glass particles, sodium lauryl sulfate (SLS), glyceryl palmitostearate, sodium benzoate, sodium stearyl fumarate, talc, and stearates (e.g., Mg or K), and waxes (e.g., glycerol monostearate, propylene glycol monostearate, and acetylated monoglycerides), stabilizers (e.g., ascorbic acid and monosterol citrate, BHT, or BHA), disintegrating agents (e.g., starch, sodium starch glycolate, cross caramellose, cross linked PVP), pH stabilizers, or preservatives. In some embodiments, the amount of filler in the oral product 110 is limited to less than 10 weight percent in sum. In some embodiments, the amount of filler in the oral product 110 is limited to be less than 5 weight percent in sum. In some embodiments, the fillers are mouth stable. In other embodiments, the fillers can dissolve or disintegrate during use and thus result in an oral product that becomes more pliable during use.
  • In some embodiments, humectants can be added help maintain the moisture levels in the oral product 110. Examples of humectants include glycerin and propylene glycol. In some embodiments, anti-microbial agents can be added to prevent spoilage and to lengthen shelf-life.
  • Sweeteners
  • A variety of synthetic and/or natural sweeteners can be used as additives in the oral product 110. Suitable natural sweeteners include sugars, for example, monosaccharides, disaccharides, and/or polysaccharide sugars, and/or mixtures of two or more sugars. According to some embodiments, the oral product 110 includes one or more of the following: sucrose or table sugar; honey or a mixture of low molecular weight sugars not including sucrose; glucose or grape sugar or corn sugar or dextrose; molasses; corn sweetener; corn syrup or glucose syrup; fructose or fruit sugar; lactose or milk sugar; maltose or malt sugar or maltobiose; sorghum syrup; mannitol or manna sugar; sorbitol or d-sorbite or d-sobitol; fruit juice concentrate; and/or mixtures or blends of one or more of these ingredients. The oral product 110 can also include non-nutritive sweeteners. Suitable non-nutritive sweeteners include: stevia, saccharin; Aspartame; sucralose; or acesulfame potassium.
  • Flavorants
  • The oral product 110 can optionally include one or more flavorants. The flavorants can be natural or artificial. Exemplary flavorants include, but are not limited to, berry flavors such as pomegranate, acai, raspberry, blueberry, strawberry, boysenberry, and/or cranberry. Other suitable flavorants include, without limitation, any natural or synthetic flavor or aroma, such as menthol, peppermint, spearmint, wintergreen, bourbon, scotch, whiskey, cognac, hydrangea, lavender, chocolate, licorice, citrus and other fruit flavors, such as apple, peach, pear, kiwi, cherry, plum, orange, lime, grape, lemon, kumquat, and grapefruit, gamma octalactone, vanillin, ethyl vanillin, breath freshener flavors, butter, rum, coconut, almond, pecan, walnut, hazelnut, French vanilla, macadamia, sugar cane, maple, cassis, caramel, banana, malt, espresso, kahlua, white chocolate, spice flavors such as cinnamon, clove, cilantro, basil, oregano, garlic, mustard, nutmeg, rosemary, thyme, tarragon, dill, sage, anise, and fennel, methyl salicylate, linalool, jasmine, coffee, olive oil, sesame oil, sunflower oil, bergamot oil, geranium oil, lemon oil, ginger oil, balsamic vinegar, rice wine vinegar, and red wine vinegar. In addition, the flavorants can include cocktail flavors, such as cosmopolitan, martini, margarita, manhattan, pina colada, daiquiri, bellini and the like. Mint oils useful in particular embodiments of the oral product 110 include spearmint and peppermint. Synthetic flavorants can also be used. The particular combination of flavorants can be selected from the flavorants that are generally recognized as safe (“GRAS”) in a particular country, such as the United States. Flavorants can also be included in the oral product as encapsulated flavorants. In some embodiments, the flavorants in the oral product 110 are limited to less than 20 weight percent in sum. In some embodiments, the flavorants in the oral product 110 are limited to be less than 10 weight percent in sum. For example, certain flavorants can be included in the oral product 110 in amounts of about 1 weight percent to 5 weight percent.
  • Fibers
  • The oral product can include fibers within the mouth-stable polymer matrix. FIG. 4 depicts an illustration of how a plurality of fibers 130 can be dispersed in a mouth-stable polymer matrix 120. As will be discussed below, the fibers can be mixed with the mouth-stable polymer prior to or during an extrusion process. As shown in FIG. 4, the fibers provide passages in the mouth-stable polymer matrix, which can permit certain additives within the mouth-stable polymer matrix to be released into an oral cavity when the oral product is received in an oral cavity and exposed to saliva. The additives can be absorbed in fiber-polymer matrix and/or form pockets within the mouth-stable polymer matrix, which can be accessed via the fibers 130. The oral product 110 can also include channels 135 formed adjacent the fibers 130. In some embodiments, the fibers are hydrophilic such that water-soluble additives can be wicked by the fibers. In some embodiments, the fibers can dissolve to leave channels. Additives 140 can be present in the mouth-stable polymer matrix 120.
  • The fibers can be cellulosic fibers. The cellulosic fibers can be derived from plant tissue. In some embodiments, the cellulosic fibers includes cellulose. The cellulosic fibers can further include lignin and/or lipids. Suitable sources for cellulosic fibers include wood pulp, cotton, sugar beets, bran, citrus pulp fiber, switch grass and other grasses, Salix (willow), tea, and Populus (poplar). In some embodiments, the cellulosic fibers can be plant tissue comprising various natural flavors, sweeteners, or active ingredients. For example, coffee beans can be ground into fibers and incorporated into the mouth-stable polymer matrix to provide a fibrous structure, flavor, and caffeine.
  • The cellulosic fibers can have a variety of dimensions. The dimensions of the fibers (in addition to the amount) can impact the release characteristics of the additives. For example, cellulosic fibers can be hydrophilic, thus water soluble additives (e.g., caffeine) can preferentially be absorbed in fiber-polymer matrix. The release profile of the additive from a polyurethane oral product 110 can be impacted by both the fiber sizes and the amounts of fiber. In certain embodiments, the cellulosic fiber can be processed to have an average fiber size of less than 200 micrometers. In particular embodiments, the fibers are between 75 and 125 micrometers. In other embodiments, the fibers are processed to have a size of 75 micrometers or less.
  • The oral product 110 can also include soluble fibers. The soluble fibers can be adapted to dissolve when exposed to saliva when the oral product 110 is received in an oral cavity. Soluble fibers can be used alone or with cellulosic fibers to provide channels 135 for additives 140 and/or 142 to be released from the oral product 110. As the soluble fibers dissolve, the oral product 110 can become more flexible and the additional channels can open up to permit the release of additional additive deposits 140 or 142. Suitable soluble fibers include psyllium fibers. In other embodiments, the fibers can be partially soluble. For example, sugar beet fibers can partially dissolve during use.
  • In some embodiments, an oral product 110 can include a combination of soluble and insoluble fibers. The ratio of soluble to insoluble fiber can impact the softness of texture of the oral product 110. The ratio of soluble to insoluble fiber can also impact the compressibility of the oral product 110. In some embodiments, a ratio of soluble to insoluble fiber is between 1:60 and 60:1. In some embodiments, the ratio of soluble to insoluble fiber is greater than 1:50, greater than 1:40, greater than 1:30, greater than 1:20, greater than 1:10, or greater than 1:5. In some embodiments, the ratio of soluble to insoluble fiber is less than 1:1, less than 1:2, less than 1:5, less than 1:10, less than 1:20, or less that 1:30. In some case, an oral product having a mixture of soluble and insoluble fibers can have a percentage of compression @ 250 N of between 60 percent and 98 percent, between 65 percent and 95 percent, between 70 percent and 90 percent, or between 80 and 89 percent.
  • The inclusion of soluble fiber can increase the compressibility of the oral product, which can also be perceived as a softer mouth feel by a consumer. The soluble and the insoluble fiber can be pre-mixed and added into the process via a single feeder. Separate fiber feeders can also be used to produce a desired ratio. In some cases, the inclusion of about 1-3% of soluble fiber and about 25-35% insoluble fiber can result in a Compression @250N of between 70% and 90%.
  • Plasticizers
  • The oral product 110 can also include one or more plasticizers. Plasticizers can soften the final oral product and thus increase its flexibility. Plasticizers work by embedding themselves between the chains of polymers, spacing them apart (increasing the “free volume”), and thus significantly lowering the glass transition temperature for the plastic and making it softer. Suitable plasticizers include propylene glycol, glycerin, vegetable oil, and medium chain triglycerides. In some embodiments, the plasticizer can include phthalates. Esters of polycarboxylic acids with linear or branched aliphatic alcohols of moderate chain length can also be used as plasticizers. Moreover, plasticizers can facilitate the extrusion processes described below. In some embodiments, the oral product 110 can include up to 20 weight percent plasticizer. In some embodiments, the oral product 110 includes between 0.5 and 10 weight percent plasticizer, the oral product 110 can include between 1 and 8 weight percent plasticizer, or between 2 and 4 weight percent plasticizer. For example, an oral product comprising a polyurethane polymer matrix and include about 3 to 6.5 weight percent of propylene glycol.
  • Molding Processes
  • The oral product 110 can be produced by extruding a mouth-stable polymer (e.g., polyurethane) with fibers (e.g., cellulosic fiber) and/or additive (e.g., caffeine) to form a rod of a mouth-stable polymer matrix including fibers and/or additives. The rod is cut into individual oral products 110. FIGS. 5A and 5B depict exemplary methods to form oral products 110.
  • Referring to the extrusion process illustrated in FIG. 5A, a mouth-stable polymer 510 (e.g., polyurethane) is introduced into an extruder for extrusion 520 along with fibers 512 (e.g., cellulosic fibers). The fibers 512 can be passed through a sieve 514 prior to introduction into the extruder. A mixture of additives 516 can also be introduced into the extruder. The mixture of additives 516 can be a solution (as shown). As shown, the additives can include a plasticizer 517 (e.g., propylene glycol) and a sweetener 518 (e.g., sucralose). The mixture of additives can also be provided in slurry form or a dry mix of powdered additives.
  • FIG. 5B illustrates an example of how the mouth-stable polymer 510 (e.g., polyurethane) can be compounded with fiber 512 and a mixture of additives 516. As shown, polyurethane pellets 510 and cellulosic fibers 512 can be introduced into an infeed section of an extruder. A first section of the extruder melts and mixes the polymer, elevating the temperature to about 150° C. The mixture 516 of propylene glycol 517 and sucralose 518 can be injected into the extruder downstream of the infeed section of the extruder. The polymer/fiber/plasticizer/sweetener mixture can then be extruded out of an extrusion die 720 at a temperature of about 150° C. An example of an extrusion die is shown in FIG. 7. For example, the extruder of FIG. 5B can operate at a mass flow rate of about 1.8 lbs/hour.
  • The polymer-fiber combination can exit an extrusion die 720 as a rod 710 and onto a moving conveyor 730, as shown in FIG. 7. The size of the extrusion die 720, the take away speed of the moving conveyor 730, the mixture of polymer-fiber combination, and the temperature of the mixture exiting the die 720 can all have an impact on the final diameter of the rod 710.
  • The extruded polymer-fiber rod 710 is then cut in a cutting process 530, as shown in FIG. 5A. The cutting can be hot-face cutting. Hot-face cutting can occur immediately after the rod 720 exits the extrusion die 720. The cutting can induce pillowing of the polymer matrix, as shown in FIG. 8. The cutting process 530 can also include a process of rounding the edges of the cut polymer-fiber composite. For example, a pelletizer can be used to round the edges. The pelletizer can also help to cool the oral products 110. In other embodiments, the extruded polymer-fiber rod 710 is cooled prior to cutting.
  • Before or after cutting, additional additives and/or flavorants can be added to the extruded polymer-fiber rod and/or pieces. As shown in FIG. 5A, a mixture of additives 550 and a mixture of flavorants 560 can be absorbed into polymer-fiber pieces in one or more absorbing processes 540. The mixture of additives 550 can include active 552 (e.g., caffeine) and water 554. A mixture of flavorants 560 can include a flavor 562 (e.g., wintergreen) and a carrier 564 (e.g., ethanol). The oral products 110 could then be dried, packaged, and sealed.
  • FIG. 6A depicts an alternative arrangement where a mouth-stable polymer 510 (e.g., polyurethane) is compounded with a mixture 516 of one or more plasticizers 517 (e.g., propylene glycol) and/or sweeteners 518 (e.g., sucralose) in a first extrusion process 622. The compounded polymer/plasticizer/sweetener mixture is then compounded with fiber 512 in a second extrusion process 624. As shown, additives such as active 552 (e.g., caffeine) and/or flavorants 562 can also be added during the second extrusion process 624. In some embodiments, the compounding in the first extrusion process occurs at a higher temperature than the compounding during the second extrusion process. Both extrusion processes can occur in a single extruder.
  • FIG. 6B depicts an arrangement of an extruder where the active, plasticizer, fibers and flavorants are all added the mouth-stable polymer in the extruder. Polyurethane pellets 510 are added to an infeed section 610 of the extruder 620. Plasticizer 517 (e.g., propylene glycol) (and optionally actives, sweeteners, and/or carriers) are injected into a first section of the extruder and compounded with the polyurethane. A vent 640 can be provided to release volatiles. Cellulosic fibers 512 can be introduced into the extruder through a side feeder 630. A flavorant mixture 560 can be added through liquid injector 660 in a flavor mixing section of the extruder. Active 52 (e.g., caffeine) and plasticizer 517 can also be injected through liquid injector 660. The mixture can then be extruded through an extrusion die 720 at a temperature of about 165° C. The extruded mixture can be hot-cut as it exits the extrusion die 720 and passed to a pelletizer. In other embodiments, the extruded mixture can be cooled on a cooling conveyer and cut. For example, the extruder of FIG. 6B can operate at a mass flow rate of about 5.5 lbs/hour. After cutting, the oral products 110 can be further flavored in a pan coater. The oral products 110 can then be sent to bulk storage and packaged.
  • In addition to the methods described above, there are many methods for making and shaping the oral products. In some embodiments, extruded and cut pieces can be introduced into a compression mold to form a final oral product shape. In other embodiments, the oral product 110 can be injection molded, compression molded, or injection-compression molded. Blocks of polymer, fiber, and/or additive can also be formed and machined into a desired shape.
  • Other Embodiments
  • It is to be understood that, while the invention has been described herein in conjunction with a number of different aspects, the foregoing description of the various aspects is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
  • Disclosed are methods and compositions that can be used for, can be used in conjunction with, can be used in preparation for, or are products of the disclosed methods and compositions. These and other materials are disclosed herein, and it is understood that combinations, subsets, interactions, groups, etc. of these methods and compositions are disclosed. That is, while specific reference to each various individual and collective combinations and permutations of these compositions and methods may not be explicitly disclosed, each is specifically contemplated and described herein. For example, if a particular composition of matter or a particular method is disclosed and discussed and a number of compositions or methods are discussed, each and every combination and permutation of the compositions and the methods are specifically contemplated unless specifically indicated to the contrary. Likewise, any subset or combination of these is also specifically contemplated and disclosed.

Claims (21)

1. (canceled)
2. An oral product comprising:
a fiber-polymer matrix including,
a mouth-stable polymer matrix, and
cellulosic fibers embedded in the mouth-stable polymer matrix; and
an additive dispersed in pores of the fiber-polymer matrix, the cellulosic fibers providing passages to the pores, the additive being configured to be released from the fiber-polymer matrix via the passages, the oral product having a compressibility at 425 N ranging from 60% to 98%.
3. The oral product of claim 2, wherein the oral product has a compressibility at 250 N ranging from 45% to 90%.
4. The oral product of claim 2, further comprising:
a plasticizer in the fiber-polymer matrix.
5. The oral product of claim 4, wherein the plasticizer includes propylene glycol, glycerin, vegetable oil, triglycerides, or any combination thereof.
6. The oral product of claim 2, further comprising:
a sweetener in the fiber-polymer matrix.
7. The oral product of claim 6, wherein the sweetener includes saccharine, sucralose, aspartame, acesulfame potassium, or any combination thereof.
8. The oral product of claim 2, wherein the additive includes a mineral, a vitamin, a dietary supplement, a nutraceutical, an energizing agent, a soothing agent, an amino acid, a chemesthetic agent, an antioxidant, botanical, a teeth whitening agent, a therapeutic agent, or any combination thereof.
9. The oral product of claim 2, further comprising:
a flavorant in the fiber-polymer matrix, the flavorant being configured to be released from the fiber-polymer matrix.
10. The oral product of claim 9, wherein the flavorant includes licorice, wintergreen, cherry and berry type flavorants, Drambuie, bourbon, scotch, whiskey, spearmint, peppermint, lavender, cinnamon, cardamon, apium graveolens, clove, cascarilla, nutmeg, sandalwood, bergamot, geranium, honey essence, rose oil, vanilla, lemon oil, orange oil, Japanese mint, cassia, caraway, cognac, jasmine, chamomile, menthol, ylang-ylang, sage, fennel, pimenta, ginger, anise, coriander, coffee, mint oils from a species of the genus Mentha, or any combination thereof.
11. The oral product of claim 2, further comprising:
an antioxidant.
12. The oral product of claim 2, wherein the mouth-stable polymer matrix includes a mouth-stable polymer including a polyurethane, a silicone polymer, a polyester, a polyacrylate, a polyethylene, a polypropylene, a polyetheramide, a polystyrene, a polyvinyl alcohol, a polyvinyl acetate, a polyvinyl chloride, polybutyl acetate, a butyl rubber, poly(styrene-ethylene-butylene-styrene), poly(styrene-butadiene-styrene), poly(styrene-isoprene-styrene), any copolymer thereof, or any combination thereof.
13. The oral product of claim 2, wherein the mouth-stable polymer includes polyurethane.
14. The oral product of claim 2, further comprising:
a soluble fiber in the fiber-polymer matrix.
15. The oral product of claim 14, wherein the soluble fiber includes maltodextrin.
16. The oral product of claim 2, wherein the fiber-polymer matrix defines a first plurality of pores having a first diameter ranging from 40 microns to 60 microns and a second plurality of pores having a second diameter ranging from 1 micron to 10 microns.
17. The oral product of claim 2, wherein a springiness of the oral product is greater than 20%.
18. The oral product of claim 17, wherein the springiness ranges from 75% to 95%.
19. The oral product of claim 2, wherein the fiber-polymer matrix is an extruded fiber-polymer matrix.
20. The oral product of claim 2, wherein the cellulosic fibers are present in an amount greater than or equal to 10% by weight of the oral product.
21. The oral product of claim 2, wherein the mouth-stable polymer matrix includes a mouth-stable polymer in an amount greater than or equal to 40% by weight of the oral product.
US16/840,820 2012-01-20 2020-04-06 Oral product Active 2033-02-21 US11541001B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US16/840,820 US11541001B2 (en) 2012-01-20 2020-04-06 Oral product
US18/055,983 US20230074150A1 (en) 2012-01-20 2022-11-16 Oral product

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261588861P 2012-01-20 2012-01-20
US13/744,905 US9884015B2 (en) 2012-01-20 2013-01-18 Oral product
US15/850,494 US10639275B2 (en) 2012-01-20 2017-12-21 Oral product
US16/840,820 US11541001B2 (en) 2012-01-20 2020-04-06 Oral product

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/850,494 Continuation US10639275B2 (en) 2012-01-20 2017-12-21 Oral product

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US18/055,983 Continuation US20230074150A1 (en) 2012-01-20 2022-11-16 Oral product

Publications (2)

Publication Number Publication Date
US20200230052A1 true US20200230052A1 (en) 2020-07-23
US11541001B2 US11541001B2 (en) 2023-01-03

Family

ID=48052735

Family Applications (4)

Application Number Title Priority Date Filing Date
US13/744,905 Active US9884015B2 (en) 2012-01-20 2013-01-18 Oral product
US15/850,494 Active US10639275B2 (en) 2012-01-20 2017-12-21 Oral product
US16/840,820 Active 2033-02-21 US11541001B2 (en) 2012-01-20 2020-04-06 Oral product
US18/055,983 Pending US20230074150A1 (en) 2012-01-20 2022-11-16 Oral product

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US13/744,905 Active US9884015B2 (en) 2012-01-20 2013-01-18 Oral product
US15/850,494 Active US10639275B2 (en) 2012-01-20 2017-12-21 Oral product

Family Applications After (1)

Application Number Title Priority Date Filing Date
US18/055,983 Pending US20230074150A1 (en) 2012-01-20 2022-11-16 Oral product

Country Status (2)

Country Link
US (4) US9884015B2 (en)
CN (1) CN103039688B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102754908B (en) 2012-01-20 2015-06-10 奥驰亚客户服务公司 Oral tobacco product
CN103039688B (en) 2012-01-20 2016-01-06 奥驰亚客户服务公司 Oral product
CN102754907B (en) 2012-01-20 2015-06-24 奥驰亚客户服务公司 Oral product
CN103040090B (en) 2012-01-20 2016-03-30 奥驰亚客户服务公司 Remove the oral product of tobacco
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
US20160157515A1 (en) 2014-12-05 2016-06-09 R.J. Reynolds Tobacco Company Smokeless tobacco pouch
KR102633916B1 (en) 2018-10-31 2024-02-06 (주)아모레퍼시픽 Granular Composition Comprising Dietary Fiber from Green Tea and Method for Preparing the Same
KR102673223B1 (en) * 2018-10-31 2024-06-07 (주)아모레퍼시픽 Granular Composition Comprising Dietary Fiber from Green Tea and Method for Preparing the Same
CN110051588A (en) * 2019-05-10 2019-07-26 德利宝(广州)香料有限公司 A kind of preparation method of chamomile mint extract essence and oral cavity composite cream containing the essence
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
CA3160750A1 (en) 2019-12-09 2021-06-17 Anthony Richard Gerardi Oral product comprising a cannabinoid
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
CA3159473A1 (en) * 2019-12-09 2021-06-17 Savannah JOHNSON Fleece for oral product with releasable component
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US11712059B2 (en) 2020-02-24 2023-08-01 Nicoventures Trading Limited Beaded tobacco material and related method of manufacture
US12016369B2 (en) 2020-04-14 2024-06-25 Nicoventures Trading Limited Regenerated cellulose substrate for aerosol delivery device
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
EP4230684A1 (en) * 2022-02-18 2023-08-23 Salamander SPS GmbH & Co. KG Composite material with aroma carrier

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1977059A (en) * 1931-04-13 1934-10-16 Frank A Garbutt Method of making a chewing gum base
US2162738A (en) 1937-08-18 1939-06-20 Clarence E Mccoy Extracting nicotine from tobacco
US3139436A (en) 1958-06-09 1964-06-30 Merck & Co Inc Nu-2-benzothiazolylsulfonylbenzamide
DE1517273B2 (en) 1965-04-15 1976-06-24 Eresta Warenhandelsgesellschaft mbH, 6052 Mühlheim PROCESS FOR CONTINUOUS EXTRACTION OF NICOTINE FROM TOBACCO AND FOR THE OBTAINING PRE-CONCENTRATED NICOTINE SALT SOLUTIONS
US4153063A (en) 1970-09-02 1979-05-08 Studiengesellschaft Kohle Mbh Process for the extraction of nicotine from tobacco
US4241090A (en) * 1978-12-21 1980-12-23 Life Savers, Inc. Non-adhesive chewing gums and method
DE3101768A1 (en) 1981-01-21 1982-08-26 Fabriques de Tabac Réunies S.A., 2003 Neuchâtel DEVICE FOR EXTRACTING LIQUID-SOLUBLE COMPONENTS FROM SMALL-CUT PLANT PRODUCTS
US4660577A (en) 1982-08-20 1987-04-28 R.J. Reynolds Tobacco Company Dry pre-mix for moist snuff
US4528993A (en) 1982-08-20 1985-07-16 R. J. Reynolds Tobacco Company Process for producing moist snuff
US4516590A (en) 1982-11-26 1985-05-14 Philip Morris Incorporated Air-cured bright tobacco filler, blends and smoking articles
JPS59166073A (en) 1983-03-10 1984-09-19 東レ株式会社 Tobacco filter
US4606357A (en) 1984-11-19 1986-08-19 Dusek Russell L Tobacco composition
ZA88128B (en) * 1987-01-30 1989-02-22 Warner Lambert Co Reduced and low-calorie sugar and sugarless chewing gum compositions containing fiber
US4983405A (en) * 1987-01-30 1991-01-08 Warner-Lambert Company Reduced and low-calorie sugar and sugarless chewing gum compositions containing fiber
US4848373A (en) 1987-04-13 1989-07-18 Helme Tobacco Company Nicotine removal process and product produced thereby
US4975270A (en) 1987-04-21 1990-12-04 Nabisco Brands, Inc. Elastomer encased active ingredients
US5176151A (en) 1987-08-27 1993-01-05 Harding Glen R Oral prophylactics
US4987907A (en) 1988-06-29 1991-01-29 Helme Tobacco Company Chewing tobacco composition and process for producing same
US4978537A (en) * 1989-04-19 1990-12-18 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5525351A (en) 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5144967A (en) 1990-10-22 1992-09-08 Kimberly-Clark Corporation Flavor release material
CN1033788C (en) * 1991-03-08 1997-01-15 不二制油株式会社 Process for preparation of water-solubility vegetable fibres, biological decomposability membrane, paste, chewing-gum and low heat foods
US5372149A (en) 1992-03-25 1994-12-13 Roth; David S. Sterilization process in the manufacturing of snuff
US5417229A (en) 1993-07-20 1995-05-23 Summers; John K. Organoleptic bite composition for human consumption
DE4416752A1 (en) 1994-05-13 1995-11-16 Schloemann Siemag Ag Process and production plant for the production of hot wide strip
US5487792A (en) 1994-06-13 1996-01-30 Midwest Research Institute Molecular assemblies as protective barriers and adhesion promotion interlayer
US5656284A (en) 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
US5906811A (en) 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
CN1207251A (en) * 1997-07-31 1999-02-10 彭泽良 Betelnut chewing-gum and its producing process
BR0016026A (en) 1999-12-30 2002-11-26 Wrigley W M Jun Co Release of lipophilic active agents from chewing gum
DK1370150T3 (en) * 2001-03-23 2008-03-25 Gumlink As t-step process for chewing gum
JP4354700B2 (en) 2001-03-23 2009-10-28 ガムリンク エー/エス Coated degradable chewing gum with improved shelf life and process for its preparation
WO2002076230A1 (en) 2001-03-23 2002-10-03 Gumlink A/S Degradable elastomers for chewing gum base
US20060157072A1 (en) 2001-06-08 2006-07-20 Anthony Albino Method of reducing the harmful effects of orally or transdermally delivered nicotine
DE60105820D1 (en) 2001-10-22 2004-10-28 Pera Ivo E Composition for reducing or weaning nicotine addiction
US20040101543A1 (en) 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
AU2003261187B2 (en) 2002-07-18 2009-10-22 Phasex Corporation Reduction of constituents in tobacco
US20040118422A1 (en) 2002-12-19 2004-06-24 Swedish Match North Europe Ab Tobacco dough and a method for its manufacture
JP4708795B2 (en) 2002-12-20 2011-06-22 ニコノヴァム エービー Physically and chemically stable nicotine-containing particulate matter
US7913700B2 (en) 2002-12-31 2011-03-29 Smokey Mountain Chew, Inc. Nontobacco moist snuff composition
US20060051455A1 (en) 2003-02-04 2006-03-09 Lone Andersen Compressed chewing gum tablet
US20040151771A1 (en) 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
ATE461681T1 (en) 2003-04-29 2010-04-15 Gen Hospital Corp METHODS AND DEVICES FOR SUSTAINED RELEASE OF MULTIPLE DRUGS
US20060112965A1 (en) 2003-08-11 2006-06-01 Whalen William F Chewing tobacco substitute containing cotinine
JP4541785B2 (en) 2003-09-01 2010-09-08 キヤノン株式会社 Vibration type actuator drive control device and vibration type actuator drive control method
ATE422355T1 (en) 2003-09-08 2009-02-15 Mcneil Ab NICOTINE FORMULATIONS AND THEIR USE
ZA200604406B (en) 2003-11-07 2008-12-31 Us Smokeless Tobacco Co Tobacco compositions
AU2004289248B2 (en) 2003-11-07 2012-05-03 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
AU2004308498A1 (en) 2003-12-22 2005-07-14 U.S. Smokeless Tobacco Company Conditioning process for tobacco and/or snuff compositions
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
WO2006000233A1 (en) 2004-06-29 2006-01-05 Fertin Pharma A/S Tobacco alkaloid containing chewing gum
CA2589489C (en) 2004-11-30 2014-04-22 Fertin Pharma A/S Method of providing fast relief to a user of a nicotine chewing gum
US7759312B2 (en) 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
EP1895992A4 (en) * 2005-05-23 2012-03-28 Kraft Foods Global Brands Llc Compressible gum based delivery systems for the release of ingredients
CN1903057A (en) * 2005-07-07 2007-01-31 陈�光 Licorice root chewing gum, and prepn. method therefor
RU2291642C1 (en) 2005-08-04 2007-01-20 Олег Иванович Квасенков Method for manufacturing canned food "schi with cabbage and potatoes" of special indication (variants)
US7819124B2 (en) 2006-01-31 2010-10-26 U.S. Smokeless Tobacco Company Tobacco articles and methods
RU2436565C2 (en) 2006-02-17 2011-12-20 Новартис Аг Disintegrating oral films
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
JP2009529343A (en) 2006-03-16 2009-08-20 ニコノヴァム エービー Chewing gum composition providing rapid release of nicotine
US8047209B2 (en) 2006-06-08 2011-11-01 May Jr Lawrence Chester Composition for tobacco substitute
CN1961732A (en) * 2006-11-20 2007-05-16 王豪良 Chewing food containing plant fiber
GB0700889D0 (en) 2007-01-17 2007-02-21 British American Tobacco Co Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
BRPI0807783A2 (en) 2007-02-23 2014-06-24 Us Smokeless Tobacco Co SMOKE-FREE TOBACCO COMPOSITION, METHODS FOR PRODUCING PLANT VARIETY AND FOR PREPARING TOBACCO WITH REDUCED AMARGOR, TOBACCO PLANT, AND CURED TOBACCO.
US8616221B2 (en) 2007-02-28 2013-12-31 Philip Morris Usa Inc. Oral pouch product with flavored wrapper
US20080233234A1 (en) 2007-03-12 2008-09-25 Wm. Wrigley Jr. Company Chewing gum and gum bases containing polyolefin thermoplastic elastomers
WO2008133982A2 (en) 2007-04-27 2008-11-06 Lectec Corporation Adhesive patch with aversive agent
WO2009007854A2 (en) 2007-06-08 2009-01-15 Philip Morris Products S.A. Oral pouch product including soluble dietary fibers
US20100260690A1 (en) 2007-09-18 2010-10-14 Arne Kristensen Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
CN107048483A (en) 2007-10-11 2017-08-18 菲利普莫里斯生产公司 Smokeless tobacco product
US8336557B2 (en) 2007-11-28 2012-12-25 Philip Morris Usa Inc. Smokeless compressed tobacco product for oral consumption
CN101932416B (en) 2007-12-21 2013-12-04 三菱化学株式会社 Fiber composite
CN201156955Y (en) 2008-02-29 2008-12-03 中国烟草总公司郑州烟草研究院 Buccal clubbed tobacco and sugar
DE102008015101A1 (en) 2008-03-19 2009-09-24 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Chewing composition and its use
US8811339B2 (en) 2008-07-07 2014-08-19 Blackberry Limited Handover schemes for wireless systems
US8349900B2 (en) 2008-08-07 2013-01-08 Valeant International Bermuda Bupropion hydrobromide polymorphs
US20110053866A1 (en) * 2008-08-12 2011-03-03 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions
US20110139166A1 (en) 2008-08-21 2011-06-16 Luzenberg Jr Robert S Tobacco Substitute
US20120031415A1 (en) 2008-11-05 2012-02-09 Swedish Match North Europe Ab Non-tobacco moist snuff composition and a method for its manufacture
CN102325472B (en) 2008-12-19 2015-07-29 美国无烟烟草有限责任公司 The method of tobacco particle and production tobacco particle
BRPI0923851A2 (en) 2008-12-31 2015-07-28 Us Smokeless Tobacco Co Tobacco article and method for producing a tobacco article.
RU2533035C2 (en) 2009-11-23 2014-11-20 Вм. Ригли Дж. Компани Chewing gum base (versions) and its manufacture method
US20110139164A1 (en) 2009-12-15 2011-06-16 R. J. Reynolds Tobacco Company Tobacco Product And Method For Manufacture
SE534627C2 (en) 2010-02-17 2011-11-01 Swedish Match North Europe Ab Oral smokeless tobacco products and oral smokeless non-tobacco snus products containing urea
US8268370B2 (en) 2010-03-26 2012-09-18 Philip Morris Usa Inc. Solid oral sensorial products including stain inhibitor
RU2587570C2 (en) 2010-04-14 2016-06-20 Алтрия Клаинт Сервисиз Инк. Moulded smokeless tobacco product
EP2566344B1 (en) 2010-05-03 2016-03-23 Intercontinental Great Brands LLC Natural chewing gum including cellulose materials
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US9587352B2 (en) 2010-05-19 2017-03-07 Suzanne M. DeVall Textiles and process for making textiles and dyes from tobacco plants
US8863756B2 (en) 2011-06-20 2014-10-21 Okono A/S Tobacco chewing gum formulation
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
CN102754907B (en) 2012-01-20 2015-06-24 奥驰亚客户服务公司 Oral product
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN103040090B (en) 2012-01-20 2016-03-30 奥驰亚客户服务公司 Remove the oral product of tobacco
CN103039688B (en) 2012-01-20 2016-01-06 奥驰亚客户服务公司 Oral product
AU2013204701B2 (en) 2012-01-20 2016-12-01 Altria Client Services Llc Oral product
CN102754908B (en) 2012-01-20 2015-06-10 奥驰亚客户服务公司 Oral tobacco product

Also Published As

Publication number Publication date
CN103039688A (en) 2013-04-17
US20130189333A1 (en) 2013-07-25
US9884015B2 (en) 2018-02-06
US11541001B2 (en) 2023-01-03
US20230074150A1 (en) 2023-03-09
US10639275B2 (en) 2020-05-05
CN103039688B (en) 2016-01-06
US20180221275A1 (en) 2018-08-09

Similar Documents

Publication Publication Date Title
US11541001B2 (en) Oral product
US11369129B2 (en) Oral product
US11517566B2 (en) Oral product
JP6560788B2 (en) Oral products
US12109313B2 (en) Soluble fiber lozenge
US20130186416A1 (en) Exhausted-tobacco oral product
AU2013204701A1 (en) Oral product
US11701810B2 (en) Methods and machines for making oral products
US20150098978A1 (en) Dissolvable-chewable tablet

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE